Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00054873
Status:
COMPLETED
Last Update Posted:
2006-07-11
First Post:
2003-02-12
Brief Title:
Tezacitabine With or Without 5-Fluorouracil 5-FU for Advanced Esophageal Cancer or Gastric Cancer
Sponsor:
Chiron Corporation
Organization:
Chiron Corporation
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2006-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy and safety of tezacitabine when given alone or in combination with 5-fluorouracil 5-FU to subjects who have advanced esophageal or gastric adenocarcinoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None